Benefit cohort | Population size (millions) | Average age at MDA treatment | Average years of health and economic benefita | Person-years (millions)b |
---|---|---|---|---|
1. Protected from acquiring infection | 21 | 20 | 45.6 | 938 |
2. Subclinical morbidity prevented from progressing | 12.5 | 20 | 45.6 | 551 |
3. Alleviated clinical disease | 12.8 | 30 | 35.6 | 450c |
Total | 46 | - | - | 1,939 |